JP2004502739A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004502739A5 JP2004502739A5 JP2002508462A JP2002508462A JP2004502739A5 JP 2004502739 A5 JP2004502739 A5 JP 2004502739A5 JP 2002508462 A JP2002508462 A JP 2002508462A JP 2002508462 A JP2002508462 A JP 2002508462A JP 2004502739 A5 JP2004502739 A5 JP 2004502739A5
- Authority
- JP
- Japan
- Prior art keywords
- gly
- asp
- peptide
- ala
- glu
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21758300P | 2000-07-12 | 2000-07-12 | |
| PCT/US2001/021944 WO2002004008A2 (en) | 2000-07-12 | 2001-07-12 | Methods of therapy with thrombin derived peptides |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004232356A Division JP2005036007A (ja) | 2000-07-12 | 2004-08-09 | トロンビン由来ペプチドを使用した治療法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004502739A JP2004502739A (ja) | 2004-01-29 |
| JP2004502739A5 true JP2004502739A5 (https=) | 2005-01-06 |
| JP3618736B2 JP3618736B2 (ja) | 2005-02-09 |
Family
ID=22811661
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002508462A Expired - Fee Related JP3618736B2 (ja) | 2000-07-12 | 2001-07-12 | トロンビン由来ペプチドを使用した治療法 |
| JP2004232356A Withdrawn JP2005036007A (ja) | 2000-07-12 | 2004-08-09 | トロンビン由来ペプチドを使用した治療法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004232356A Withdrawn JP2005036007A (ja) | 2000-07-12 | 2004-08-09 | トロンビン由来ペプチドを使用した治療法 |
Country Status (10)
| Country | Link |
|---|---|
| US (5) | US6867190B2 (https=) |
| EP (1) | EP1253937B1 (https=) |
| JP (2) | JP3618736B2 (https=) |
| CN (1) | CN100500211C (https=) |
| AT (1) | ATE249238T1 (https=) |
| AU (2) | AU2001278907B2 (https=) |
| CA (1) | CA2415778A1 (https=) |
| DE (2) | DE60100740T4 (https=) |
| TW (1) | TWI257307B (https=) |
| WO (1) | WO2002004008A2 (https=) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6774278B1 (en) * | 1995-06-07 | 2004-08-10 | Cook Incorporated | Coated implantable medical device |
| US6346510B1 (en) * | 1995-10-23 | 2002-02-12 | The Children's Medical Center Corporation | Therapeutic antiangiogenic endostatin compositions |
| AU2002241917B2 (en) * | 2000-07-12 | 2006-06-15 | The Board Of Regents, The University Of Texas System | Thrombin derived peptides for promoting cardiac tissue repair |
| TWI257307B (en) * | 2000-07-12 | 2006-07-01 | Orthologic Corp | Pharmaceutical composition for cardiac tissue repair |
| DE10115740A1 (de) * | 2001-03-26 | 2002-10-02 | Ulrich Speck | Zubereitung für die Restenoseprophylaxe |
| CA2511223A1 (en) * | 2002-01-16 | 2003-07-31 | The Board Of Regents, The University Of Texas System | Thrombin derived peptides for promoting cardiac tissue repair |
| AU2003247848B2 (en) * | 2002-07-02 | 2006-12-21 | The Board Of Regents, The University Of Texas System | Thrombin peptide derivative dimers |
| EP1539214A4 (en) * | 2002-07-02 | 2008-01-02 | Orthologic Corp | Thrombin |
| DK1521603T3 (da) * | 2002-07-12 | 2011-04-18 | Cook Inc | Coated medicinsk anordning |
| DE10244847A1 (de) * | 2002-09-20 | 2004-04-01 | Ulrich Prof. Dr. Speck | Medizinische Vorrichtung zur Arzneimittelabgabe |
| MXPA05008519A (es) | 2003-02-12 | 2005-10-20 | Monsanto Technology Llc | Forma de algodon mon 88913 y composiciones y metodos para detectarla. |
| US8383158B2 (en) * | 2003-04-15 | 2013-02-26 | Abbott Cardiovascular Systems Inc. | Methods and compositions to treat myocardial conditions |
| PL1559431T3 (pl) | 2003-12-31 | 2007-10-31 | Orthologic Corp | Kompozycja farmaceutyczna dla pochodnych peptydu trombiny |
| US20060063930A1 (en) * | 2004-08-20 | 2006-03-23 | Agoston Gregory E | Compositions and methods comprising proteinase activated receptor antagonists |
| US9539410B2 (en) | 2005-04-19 | 2017-01-10 | Abbott Cardiovascular Systems Inc. | Methods and compositions for treating post-cardial infarction damage |
| US20080125745A1 (en) | 2005-04-19 | 2008-05-29 | Shubhayu Basu | Methods and compositions for treating post-cardial infarction damage |
| JP2006321740A (ja) * | 2005-05-18 | 2006-11-30 | Kanazawa Univ | 虚血後血管新生促進剤 |
| US9242005B1 (en) | 2006-08-21 | 2016-01-26 | Abbott Cardiovascular Systems Inc. | Pro-healing agent formulation compositions, methods and treatments |
| CN101563102B (zh) | 2006-09-22 | 2014-12-17 | 德克萨斯系统大学董事会 | 治疗内皮功能障碍的方法 |
| US9005672B2 (en) | 2006-11-17 | 2015-04-14 | Abbott Cardiovascular Systems Inc. | Methods of modifying myocardial infarction expansion |
| US8227412B2 (en) * | 2007-03-29 | 2012-07-24 | Tsopanoglou Nikos E | Bioactive parstatin peptides and methods of use |
| US20100303793A1 (en) * | 2007-04-10 | 2010-12-02 | The Board Of Regents, The University Of Texas Syst | Combination therapy for cardiac revascularization and cardiac repair |
| US8202528B2 (en) * | 2007-06-05 | 2012-06-19 | Abbott Cardiovascular Systems Inc. | Implantable medical devices with elastomeric block copolymer coatings |
| GB2450747A (en) * | 2007-07-06 | 2009-01-07 | Univ Sheffield | Treatment of sensorineural hearing loss |
| US8586398B2 (en) * | 2008-01-18 | 2013-11-19 | Miasole | Sodium-incorporation in solar cell substrates and contacts |
| AU2009229395A1 (en) * | 2008-03-26 | 2009-10-01 | The Board Of Regents, The University Of Texas System | Method of treating degenerative diseases |
| AU2009229399A1 (en) * | 2008-03-26 | 2009-10-01 | Orthologic Corp. | Thrombin derived peptides for smooth muscle relaxation |
| JP2011515471A (ja) * | 2008-03-26 | 2011-05-19 | オーソロジック コーポレイション | 急性心筋梗塞を処置するための方法 |
| CA2722620A1 (en) * | 2008-03-26 | 2009-10-01 | Orthologic Corp. | Method of treating peripheral arterial disease |
| WO2010033862A2 (en) * | 2008-09-19 | 2010-03-25 | The Board Of Regents, The University Of Texas System | Methods for treating cancer |
| US20130101574A1 (en) * | 2010-06-11 | 2013-04-25 | Darrell H. Carney | Methods of using thrombin peptide derivatives |
| GB201314312D0 (en) * | 2013-08-09 | 2013-09-25 | Regentec Ltd | Composition and delivery system |
| US20160039876A1 (en) | 2014-03-28 | 2016-02-11 | Claresa Levetan | Insulin independence among patients with diabetes utilizing an optimized hamster reg3 gamma peptide |
| US10220078B2 (en) | 2014-06-11 | 2019-03-05 | The Board Of Regents Of The University Of Texas System | Methods of using thrombin derivatives to treat medulloblastoma |
| EP3952991A4 (en) * | 2019-04-12 | 2023-08-09 | Affirmed Pharma, LLC | RUSALATIDE ACETATE COMPOSITIONS |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5352664A (en) * | 1986-10-31 | 1994-10-04 | Board Of Regents, The University Of Texas System | Thrombin derived polypeptides; compositions and methods for use |
| US5244460A (en) * | 1991-11-27 | 1993-09-14 | The United States Of America As Represented By The Department Of Health And Human Services | Method to foster myocardial blood vessel growth and improve blood flow to the heart |
| US6086866A (en) | 1993-04-29 | 2000-07-11 | Kouri; Roger Khalil | Use of platelet-derived growth factor to improve collateral circulation |
| DE69633133T2 (de) * | 1995-10-24 | 2005-07-28 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | TFPI-verwandte Peptide die das Wachstums von glatten Muskelzellen inhibieren |
| US5912229A (en) * | 1996-03-01 | 1999-06-15 | Novo Nordisk Als | Use of a pharmaceutical composition comprising an appetite-suppressing peptide |
| US6197751B1 (en) * | 1997-11-10 | 2001-03-06 | The United States Of America As Represented By The Department Of Health And Human Services | Thymosin α1 promotes tissue repair, angiogenesis and cell migration |
| US6033436A (en) * | 1998-02-17 | 2000-03-07 | Md3, Inc. | Expandable stent |
| IL139030A0 (en) | 1998-04-17 | 2001-11-25 | Angiogenix Inc | Therapeutic angiogenic factors and methods for their use |
| EP1126870B1 (en) | 1998-10-26 | 2004-09-08 | Ludwig Institute For Cancer Research | Use of vegf-c or vegf-d gene or protein to prevent restenosis |
| US6363938B2 (en) * | 1998-12-22 | 2002-04-02 | Angiotrax, Inc. | Methods and apparatus for perfusing tissue and/or stimulating revascularization and tissue growth |
| TWI257307B (en) * | 2000-07-12 | 2006-07-01 | Orthologic Corp | Pharmaceutical composition for cardiac tissue repair |
-
2001
- 2001-07-11 TW TW090116938A patent/TWI257307B/zh not_active IP Right Cessation
- 2001-07-12 JP JP2002508462A patent/JP3618736B2/ja not_active Expired - Fee Related
- 2001-07-12 DE DE60100740T patent/DE60100740T4/de not_active Expired - Lifetime
- 2001-07-12 CA CA002415778A patent/CA2415778A1/en not_active Abandoned
- 2001-07-12 CN CNB018154581A patent/CN100500211C/zh not_active Expired - Fee Related
- 2001-07-12 AU AU2001278907A patent/AU2001278907B2/en not_active Ceased
- 2001-07-12 DE DE60100740A patent/DE60100740D1/de not_active Expired - Lifetime
- 2001-07-12 AU AU7890701A patent/AU7890701A/xx active Pending
- 2001-07-12 WO PCT/US2001/021944 patent/WO2002004008A2/en not_active Ceased
- 2001-07-12 EP EP01957136A patent/EP1253937B1/en not_active Expired - Lifetime
- 2001-07-12 AT AT01957136T patent/ATE249238T1/de active
- 2001-07-12 US US09/904,090 patent/US6867190B2/en not_active Expired - Lifetime
-
2002
- 2002-01-16 US US10/050,611 patent/US6861407B2/en not_active Expired - Fee Related
-
2004
- 2004-08-09 JP JP2004232356A patent/JP2005036007A/ja not_active Withdrawn
- 2004-09-30 US US10/957,427 patent/US7034001B2/en not_active Expired - Fee Related
-
2005
- 2005-12-02 US US11/293,495 patent/US7214661B2/en not_active Expired - Fee Related
-
2007
- 2007-04-13 US US11/787,114 patent/US7732411B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004502739A5 (https=) | ||
| RU2400256C2 (ru) | Захват эндотелиальных клеток-предшественников элюирующим лекарственные средства имплантируемым медицинским устройством | |
| ES2379574T3 (es) | Copolímeros de metacrilato para dispositivos médicos | |
| US7887572B2 (en) | Implantable devices for accelerated healing | |
| US20070003589A1 (en) | Coatings for implantable medical devices containing attractants for endothelial cells | |
| US8062350B2 (en) | RGD peptide attached to bioabsorbable stents | |
| US20090299133A1 (en) | Ventricular infarct assist device and methods for using it | |
| DE60100740D1 (de) | Verwendung von thrombin-derivierten peptiden zur therapie von kardiovaskuläre krankheiten | |
| JP5752033B2 (ja) | 遺伝子組み換えゼラチンを含む血管新生誘導剤 | |
| JP5153340B2 (ja) | 薬剤放出制御組成物および薬剤放出性医療器具 | |
| JP2008521495A (ja) | 生体有益性コーティングとしてのポリ（エステルアミド）誘導体 | |
| JP2008517717A (ja) | 末端封止されたポリ（エステルアミド）共重合体 | |
| JP2003521354A (ja) | 医療装置 | |
| JP2002528420A5 (https=) | ||
| WO2010147109A1 (ja) | 遺伝子組み換えゼラチン及び塩基性線維芽細胞増殖因子を含む血管新生誘導剤 | |
| JPWO1997015598A1 (ja) | 新規ペプチド | |
| JP4338516B2 (ja) | 血管新生剤 | |
| WO1999049907A1 (en) | Medical devices treated to discourage blood coagulation | |
| JP2008529742A (ja) | 内皮細胞の誘引物質を含む植込み型医療装具の被膜 | |
| DE60239705D1 (de) | Thrombin-derivierten peptiden zur förderung von herzgewebsreparatur | |
| US20250281679A1 (en) | Biomimetic coating for endovascular stent | |
| Siddavaram | Covered stent treatment of coronary aneurysm in an octogenarian | |
| JPWO2023099957A5 (https=) | ||
| JPH06157332A (ja) | 血管再建術後血管再狭窄及び動脈硬化の治療用医薬組成物 | |
| TH78436A (th) | การใช้เพปไทด์ซึ่งได้มาจากธรอมบินในการผลิตยาเพื่อรักษาความผิดปกติที่เกี่ยวข้องกับหลอดเลือดหัวใจ |